Chairman and Chief Executive Officer
Member of the Board of ALR Technologies Inc.
Mr. Chan oversees the strategic planning of the company to achieve its mission to deliver innovative technology based solutions to improve health outcomes while reducing health care costs.
Mr. Chan has been involved in managing and developing ALR Technologies since August 1997 and was instrumental in taking the company public. Prior to ALR, Mr. Chan had an extensive background in structured finance as President and CEO of the Knight's Group of Companies. Prior to the founding of the Knight's Group of Companies Mr. Chan worked for the predecessor companies of RBC Dominion Securities as well as Cominco, the mining subsidiary of Canadian Pacific.
Mr. Chan is an engineer who obtained his Bachelor of Engineering degree with the distinction in Mineral Economics from McGill University.
Director, Diabetes Care Facilitation
Dr. Stoneking oversees the hiring, training, and ongoing activities of ALRT's Diabetes Care Facilitators (DCFs) who monitor the data of diabetes patients and coordinate care with clinicians, caregivers, health plans and others.
Dr. Stoneking is a Certified Diabetes Educator (CDE) who has gained extensive, hands-on experience working with a network of internal medicine and family practice physicians to assist patients with diabetes education and self-management training. He received his Doctor of Pharmacy from the University of Tennessee and is an affiliate member of the American Diabetes Association and the American Pharmacists Association. Dr. Stoneking is Chair of Pharmacy Practice at Union University School of Pharmacy, Jackson, Tennessee.
Dr. Stoneking received his B.S. in biology from the University of Memphis and his Pharm.D. from the University of Tennessee College of Pharmacy.
Mr. Chan has been involved in managing ALR Technologies since August 1997. Since then, he has played a pivotal role in the evolution of ALR Technologies into a public company. Mr. Chan has been extensively involved in the company's finances and product development. Mr. Chan is an engineer who obtained his Bachelor of Engineering degree with the distinction in Mineral Economics from McGill University in 1973.
Dr. Salas graduated with distinction from Universidad Metroplitana of Barranquilla, Colombia in 1983 with a Doctor of Medicine degree. He began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in 1984. He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in 1991 doing medical assessments for work related accidents. In 1993 Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since 1995 Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations and agencies in Columbia with a focus on budgeting, research and medical services.
Mr. Robulak has had an extensive career in corporate finance with major Canadian financial institutions, more recently he provides support services for a manufacturing Company with operations in Dallas, Texas and Guadalajara, Mexico. Mr. Robulak joined the board of ALR Technologies Inc. on December 14, 1999 and served as chief financial officer, secretary and treasurer from April 4, 2000 until he resigned on January 31, 2001 to go to work with Morgan Stanley. Mr. Robulak earned a Bachelor of Commerce degree in finance and marketing and is a Fellow of the Institute of Canadian Bankers.
Mr. Stafford is a retired lawyer and business consultant, having practised with Fasken Martineau DuMoulin LLP, a major Canadian based international law firm, and its predecessor firms, from 1966 to 2013, except for several years spent as in-house counsel for clients of the firm. Mr. Stafford's experience is in the areas of corporate and securities law, including mergers and acquisitions. From 1989 until his retirement from full-time practice, Mr. Stafford served as senior partner in the business law department at Faskin Martineu DuMoulin LLP, including leading the start of its Johannesburg office in 2003. Since August 2013, Mr. Stafford has served as director, secretary and audit committee chair of Russell Breweries Inc. Formerly, he was a director and subsequently secretary of WEX Pharmaceuticals Inc. until its amalgamation, a director and board chair of BC Bancorp from until its merger with Canadian Western Bank, a director of China One Corporation until it was acquired and a director of a director of Nissho Iwai (Canada) Ltd. Originally from South Africa, Mr. Stafford obtained a BA from the University of Cape Town and an LL.B from the University of South Africa. He was admitted as an attorney in South Africa and subsequently was called to the English Bar (Inner Temple).
Mr. Cheng is a lawyer retired from Osler, Hoskin and Harcourt LLP, a major Canadian based international law firm. He regularly appeared as counsel before the Canadian International Trade Tribunal, federal courts, on NAFTA and WTO matters and advised on NAFTA and other trade agreements. He represented and provided strategic advice to corporations including startups, trade associations and governments in anti-dumping, countervail and safeguard litigation, customs matters, commodity tax and government procurement disputes, as well import and export monitoring and controls. Mr. Cheng is listed in the Lexpert® Guides to Leading US/Canada Cross-border Litigation Lawyers and with highest listings in other leading legal directories such as Chambers, Martindale-Hubbell and Best Lawyers. He has a BA, Amherst College; JD, University of Toronto and is an active member of the CBA, ABA, IBA and IPBA.